[1]
«Compaction and Tableting Behavior of a Novel Co-Processed Excipient in the Formulation of Metoprolol Succinate Tablets», NJPR, libk. 16, zenb. 2, or. 127–142, abe. 2020, doi: 10.4314/njpr.v16i2.4.